4
Changes in Ownership
Allogene Therapeutics, Inc. Filed Acc 0001362155-26-000002
SVP, General Counsel sold 22,900 shares at $1.76 ($40,304)
From the SEC's structured data for this filing
Trades in this filing
Loading xslF345X05/wk-form4_1770243135.xml…